Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Multiple Sclerosis

Free Subscription 16.03.2026 1 AJNR Am J Neuroradiol 1 Arch Phys Med Rehabil 1 BMC Neurol 1 Brain 1 J Clin Invest 3 J Neuroimmunol 7 J Neurol 2 J Neurol Sci 7 Mult Scler 1 Nat Rev Neurol 1 Nervenarzt 1 Neurol Clin Pract 3 Neurology 1 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. OKUDA DT, Punnen TG, Moog TM, McCreary MC, et al
   Understanding the Therapeutic Impact of Disease-Modifying Therapies or No Treatment on Enlarging T1-Weighted Hypointense Lesions and Total T1-Weighted Hypointense Lesion Volume in MS.
   AJNR Am J Neuroradiol. 2026;47:843-851.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

2. BPHTY TR, Hillier S, Serrada I, Gerges A, et al
   Group vs Individual Therapy for Neurological Recovery: A Systematic Review and Meta-Analysis.
   Arch Phys Med Rehabil. 2025 Aug 27:S0003-9993(25)00868.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. MACHADO A, Dervish J, Friberg E
   Employment status and self-rated health in people with multiple sclerosis in Sweden.
   BMC Neurol. 2026 Mar 11. doi: 10.1186/s12883-026-04809.
   PubMed        
   
   

   
   Brain

4. CORAZZOLLA G, Treaba CA, Mohammadian M, Brusaferri L, et al
   Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression.
   Brain. 2026 Mar 9:awag084. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Clin Invest

5. LEE-CHANG C
   Organized immunity in the CNS: what stroke reveals about neuroinflammation and lymphoid niches.
   J Clin Invest. 2026;136:e202688.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

6. ATASEVER U
   Bile acid-microbiota interactions in multiple sclerosis: From experimental models to early clinical evidence.
   J Neuroimmunol. 2026;415:578898.
   PubMed         Abstract available
   
   
7. DAMSBO K, Reyahi A, Nik AM, Oubounyt M, et al
   Astrocyte-specific FoxF2 modulates immune and myelin repair: Evidence from multiple sclerosis lesions and an animal model.
   J Neuroimmunol. 2026;415:578896.
   PubMed         Abstract available
   
   
8. SARIN S, Modak N, Sun R, Subei O, et al
   Predicting the final clinical phenotype after the first attack of optic neuritis.
   J Neuroimmunol. 2023;381:578130.
   PubMed         Abstract available
   
   

   
   J Neurol

9. BERGAMASCHI R, Ferraro OE, Enrico P, Marzia F, et al
   Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.
   J Neurol. 2026;273:172.
   PubMed         Abstract available
   
   
10. KLEIN KRANENBARG RAM, Blok KM, van Hasselt Y, Melisse S, et al
    Symptoms of depression and anxiety are early predictors of multi-domain disability progression in progressive MS.
    J Neurol. 2026;273:182.
    PubMed         Abstract available
    
    
11. MOLENAAR PCG, de Jong DJ, Hof SN, van Oirschot P, et al
    Digital monitoring of disease activity in relapsing-remitting multiple sclerosis.
    J Neurol. 2026;273:186.
    PubMed         Abstract available
    
    
12. FREEDMAN DE, Benedict RHB, Oh J, Feinstein A, et al
    The non-linear relationship between self-reported cognitive concerns and performance-based cognitive dysfunction in people with multiple sclerosis: a cross-sectional study.
    J Neurol. 2026;273:190.
    PubMed         Abstract available
    
    
13. CANDELORO R, Laudisi M, Ferri C, Baldi E, et al
    Beyond oligoclonal bands: the independent role of kappa free light chains in the diagnostic workup of multiple sclerosis.
    J Neurol. 2026;273:191.
    PubMed         Abstract available
    
    
14. DIMITRIADOU EM, Tzanetakos D, Theodorou A, Akrivaki A, et al
    The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naive patients with multiple sclerosis.
    J Neurol. 2026;273:194.
    PubMed         Abstract available
    
    
15. GUERRA T, Lucisano G, Rocca MA, Cocco E, et al
    HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.
    J Neurol. 2026;273:193.
    PubMed         Abstract available
    
    

    
    J Neurol Sci

16. RICAURTE-FAJARDO A, Garcia Gonzalez K, Merino Campo S, Alvarado-De la Hoz C, et al
    Integrated determinants of multiple sclerosis susceptibility: Genetics, environment, infection and the microbiota.
    J Neurol Sci. 2026;484:125865.
    PubMed         Abstract available
    
    
17. IANNIELLO A, Piervincenzi C, Pozzilli C, Satriano F, et al
    A proof-of-concept study on the relationship between lifetime Estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis.
    J Neurol Sci. 2026;484:125854.
    PubMed         Abstract available
    
    

    
    Mult Scler

18. SIVA A, Kantarci O
    Multiple sclerosis controversies: Do MRI-negative relapses really exist? - Commentary.
    Mult Scler. 2026 Mar 3:13524585261423082. doi: 10.1177/13524585261423082.
    PubMed        
    
    
19. ABAD-INCHAURRONDO I, Lu S, Lui E, Susin-Calle S, et al
    Performance of the 2024 McDonald diagnostic criteria for multiple sclerosis.
    Mult Scler. 2026 Mar 3:13524585261421816. doi: 10.1177/13524585261421816.
    PubMed         Abstract available
    
    
20. CORONA A, Clarelli F, Paakkonen K, Harroud A, et al
    Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.
    Mult Scler. 2026 Mar 3:13524585261417130. doi: 10.1177/13524585261417130.
    PubMed         Abstract available
    
    
21. SPAGNOLO F, Gordaliza PM, Bhardwaj A, Lu PJ, et al
    A multi-modal deep learning network for the classification of paramagnetic rim and remyelinated lesions in multiple sclerosis.
    Mult Scler. 2026 Mar 6:13524585261421491. doi: 10.1177/13524585261421491.
    PubMed         Abstract available
    
    
22. EBRAHIMI A, Wiil UK, Olsson T, Lio P, et al
    A susceptibility network analysis of disease trajectories leading to multiple sclerosis: A nationwide cohort study.
    Mult Scler. 2026 Mar 10:13524585261421480. doi: 10.1177/13524585261421480.
    PubMed         Abstract available
    
    
23. NOVA A, Di Caprio G, Gentilini D, Bernardinelli L, et al
    A bidirectional two-sample Mendelian randomization study of immune responses against Epstein-Barr virus nuclear antigen 1 and multiple sclerosis in individuals of European ancestry.
    Mult Scler. 2026 Mar 10:13524585261423063. doi: 10.1177/13524585261423063.
    PubMed         Abstract available
    
    
24. INOJOSA H, Mathias R, Dillenseger A, Voigt I, et al
    AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research.
    Mult Scler. 2026 Mar 13:13524585261424136. doi: 10.1177/13524585261424136.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

25. GRIMSEY B
    We need to talk about risk in multiple sclerosis.
    Nat Rev Neurol. 2026;22:137.
    PubMed        
    
    

    
    Nervenarzt

26. KLIMAS R, Karl AS, Poser PL, Sgodzai M, et al
    [Over one year of B?cell targeted therapy with Ofatumumab s.c.: first results of a prospective, patient-centered real-world observational study].
    Nervenarzt. 2023;94:923-933.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

27. BOVE R, Simoni M, Castelo-Branco C, Correale J, et al
    Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program.
    Neurol Clin Pract. 2026;16:e200588.
    PubMed         Abstract available
    
    

    
    Neurology

28. KIM SH, Lee EJ, Lim YM, Kim H, et al
    Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.
    Neurology. 2026;106:e214792.
    PubMed         Abstract available
    
    
29. JACOBS BM, Schalk L, Tregaskis-Daniels E, Scalfari A, et al
    Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.
    Neurology. 2026;106:e214708.
    PubMed         Abstract available
    
    
30. MARTINEZ SOSA S, Tisavipat N, Betting T, Guo Y, et al
    Pearls & Oy-sters: Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis.
    Neurology. 2026;106:e214794.
    PubMed         Abstract available
    
    

    
    PLoS One

31. GIORDANO A, De Panfilis L, Zagarella RM, Di Domenico G, et al
    Communication competences of multiple sclerosis neurologists during advance care planning conversations: A multi-observer study.
    PLoS One. 2026;21:e0336183.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. LUM FM, Sattarnezhad N, Ho PP, Orr N, et al
    Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2026;123:e2519445123.
    PubMed         Abstract available
    
    
33. CHIA PHJ, Toyonaga T, Tong J, Le H, et al
    SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.
    Proc Natl Acad Sci U S A. 2026;123:e2517709123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum